Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection

被引：11

作者：

van Rossum, AMC ^{[1
]}

de Groot, R

Hartwig, NG

Weemaes, CMR

Head, S

Burger, DM

机构：

[1] Erasmus Univ, Sophia Childrens Hosp, Med Ctr, Dept Paediat, Rotterdam, Netherlands

[2] Univ Nijmegen, Med Ctr St Radboud, Dept Paediat, Nijmegen, Netherlands

[3] St Marys NHS Trust, Dept Paediat, London, England

[4] Univ Nijmegen, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands

来源：

AIDS | 2000年 / 14卷 / 14期

关键词：

D O I：

10.1097/00002030-200009290-00022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2209 / 2210

页数：2

共 10 条

[1]

BURGER DM, 1999, 6 C RETR OPP INF CHI

[2] Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients [J].

Dieleman, JP ;

Gyssens, IC ;

van der Ende, ME ;

de Marie, S ;

Burger, DM .

AIDS, 1999, 13 (04) :473-478

[3] Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children [J].

Funk, MB ;

Linde, R ;

Wintergerst, U ;

Notheis, G ;

Hoffmann, F ;

Schuster, T ;

Kornhuber, B ;

Ahrens, P ;

Kreuz, W .

AIDS, 1999, 13 (13) :1653-1658

[4]

GIBALDI M, 1999, BIOPHARMACEUTICS CLI

[5] Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers [J].

Hsu, A ;

Granneman, GR ;

Cao, GL ;

Carothers, L ;

Japour, A ;

El-Shourbagy, T ;

Dennis, S ;

Berg, J ;

Erdman, K ;

Leonard, JM ;

Sun, EG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2784-2791

[6] Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography [J].

Hugen, PWH ;

Verweij-van Wissen, CPWGM ;

Burger, DM ;

Wuis, EW ;

Koopmans, PP ;

Hekster, YA .

JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :139-149

[7]

NELSON R, 1999, 6 C RETR OPP INF CHI

[8] Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands [J].

van Rossum, AMC ;

Niesters, HGM ;

Geelen, SPM ;

Scherpbier, HJ ;

Hartwig, NG ;

Weemaes, CMR ;

Veerman, AJP ;

Suur, MH ;

de Graeff-Meeder, ER ;

Slicker, WAT ;

Hop, WCJ ;

Osterhaus, ADME ;

Burger, DM ;

de Groot, R .

JOURNAL OF PEDIATRICS, 2000, 136 (06) :780-788

[9] Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection [J].

Viganó, A ;

Dally, L ;

Bricalli, D ;

Sala, N ;

Pirillo, M ;

Saresella, M ;

Trabattoni, D ;

Vella, S ;

Clerici, M ;

Principi, N .

JOURNAL OF PEDIATRICS, 1999, 135 (06) :675-682

[10] Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus [J].

Wintergerst, U ;

Hoffmann, F ;

Sölder, B ;

Notheis, G ;

Petropoulou, T ;

Eberle, J ;

Gurtler, L ;

Belohradsky, BH .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (06) :495-499

← 1 →